You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Claims for Patent: 5,658,929

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,658,929

Title:	Sulfonamide fibrinogen receptor antagonists
Abstract:	A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
Inventor(s):	Duggan; Mark E. (Narberth, PA), Egbertson; Melissa S. (Ambler, PA), Halczenko; Wasyl (Hatfield, PA), Hartman; George D. (Lansdale, PA), Laswell; William L. (Perkasie, PA)
Assignee:	Merck & Co., Inc. (Rahway, NJ)
Application Number:	08/505,417
Patent Claims:	1. A compound selected from the group consisting of: ##STR214## and pharmaceutically acceptable salts thereof. 2. A compound of claim 1 which is ##STR215## 3. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier. 4. A pharmaceutical composition comprising a compound of claim 2 and a pharmaceutically acceptable carrier.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.